Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era.

Details

Serval ID
serval:BIB_B00FAF22A774
Type
Article: article from journal or magazin.
Collection
Publications
Title
Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era.
Journal
Journal of the International AIDS Society
Author(s)
Cao W., Mehraj V., Kaufmann D.E., Li T., Routy J.P.
ISSN
1758-2652 (Electronic)
ISSN-L
1758-2652
Publication state
Published
Issued date
2016
Peer-reviewed
Oui
Volume
19
Number
1
Pages
20697
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Publication Status: epublish
Abstract
HIV infection leads to a disturbed T-cell homeostasis, featured by a depletion of CD4 T-cells and a persistent elevation of CD8 T-cells over disease progression. Most effort of managing HIV infection has been focused on CD4 T-cell recovery, while changes in the CD8 compartment were relatively underappreciated in the past.
A comprehensive literature review of publications in English language was conducted using major electronic databases. Our search was focused on factors contributing to CD8 T-cell dynamics in HIV infection and following antiretroviral therapy (ART).
Normalization of CD8 counts is seldom observed even with optimal CD4 recovery following long-term treatment. Initiation of ART in primary HIV infection leads to enhanced normalization of CD8 count compared with long-term ART initiated in chronic infection. Importantly, such CD8 elevation in treated HIV infection is associated with an increased risk of inflammatory non-AIDS-related clinical events independent of CD4 T-cell recovery. The mechanisms underlying CD8 persistence remain largely unknown, which may include bystander activation, exhaustion and immunosenescence of CD8 T-cells. The information provided herein will lead to a better understanding of factors associated with CD8 persistence and contribute to the development of strategies aiming at CD8 normalization.
Persistence of CD8 T-cell elevation in treated HIV-infected patients is associated with an increased risk of non-AIDS-related events. Now that advances in ART have led to decreased AIDS-related opportunistic diseases, more attention has been focused on reducing non-AIDS events and normalizing persistent CD8 T-cell elevation.
Keywords
Anti-HIV Agents/therapeutic use, CD8-Positive T-Lymphocytes/immunology, Female, HIV Infections/drug therapy, HIV Infections/immunology, Humans, CD8 T-cell persistence, HIV, T-cell exhaustion, antiretroviral therapy, bystander activation
Pubmed
Web of science
Open Access
Yes
Create date
09/05/2023 12:59
Last modification date
29/11/2024 17:02
Usage data